Interventional Oncology Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION
Interventional oncology procedures includes diagnosis and treatment with use of minimally invasive surgery, which are carried under image guidance. Medical devices like X-ray, computed tomography and magnetic resonance imaging is used for the treatment. This technique is generally used for lung cancer, liver cancer and kidney cancer.

MARKET DYNAMICS
The interventional oncology market is to grow exponentially in the forecast period owing to driving factors such as increasing rising preference for minimally invasive surgeries, increase in patient population and increasing public-private funding for interventional oncology. In addition, the emerging economies and growing awareness about interventional oncology is anticipated to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Interventional Oncology Market Analysis to 2031" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of interventional oncology market with detailed market segmentation by product, procedure, cancer and geography. The global interventional oncology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading interventional oncology market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global interventional oncology market is segmented on the basis of product, procedure and cancer. Based on product, the market is classified as embolization devices, ablation devices and support devices. On the basis of procedure the market is categorised as thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization, transcatheter arterial radioembolization or selective internal radiation and therapy transcatheter arterial embolization or bland embolization. On the basis of cancer type the interventional oncology market is classified as liver cancer, lung cancer, bone cancer, kidney cancer and other cancer. REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global interventional oncology market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The interventional oncology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting interventional oncology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the interventional oncology market in these regions.

Interventional Oncology Market Report Analysis

Interventional Oncology Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• BTG International Ltd.
• HealthTronics, Inc.
• IceCure Medical Ltd
• IMBIOTECHNOLOGIES LTD.
• Medtronic
• MedWaves, Inc.
• Sanarus
• Teleflex Incorporated
• Terumo Corporation

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Product

• Embolization Devices
• Ablation Devices
• Support Devices

By Procedure

• Thermal Tumor Ablation
• Non-Thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization or Selective Internal Radiation Therapy
• Transcatheter Arterial Embolization or Bland Embolization

By Cancer Type

• Liver Cancer
• Lung Cancer
• Bone Cancer
• Kidney Cancer
• Other Cancers

MARKET PLAYERS
The reports cover key developments in the interventional oncology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from interventional oncology market are anticipated to lucrative growth opportunities in the future with the rising demand for interventional oncology market in the global market. Below mentioned is the list of few companies engaged in the interventional oncology market.

The report also includes the profiles of key interventional oncology market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• BTG International Ltd.
• HealthTronics, Inc.
• IceCure Medical Ltd
• IMBIOTECHNOLOGIES LTD.
• Medtronic
• MedWaves, Inc.
• Sanarus
• Teleflex Incorporated
• Terumo Corporation
• Trod Medical

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Interventional Oncology Market Report Scope